Skip to main content

Want a detailed portfolio tracker?

Performance analysis of Repare Therapeutics (RPTX)

Annual Return

Over the past 3 years, RPTX has had an average annual return of -42.36%, underperforming the benchmark SPY, which returned +21.81% annual.

Over the past 5 years, RPTX has had an average annual return of -41.13%, underperforming the benchmark SPY, which returned +12.93% annual.

Since Jun 19, 2020, RPTX has had an average annual return of -35.41%, underperforming the benchmark SPY, which returned +17.17% annual.

2026202520242023202220212020
+1.90%+98.59%-82.07%-50.38%-30.25%-38.51%+11.36%

Monthly Return

YearJanFebMarAprMayJunJulAugSepOctNovDecAnnually Total
2026+1.90%+1.90%
2025-6.82%-3.28%-16.45%+39.06%-0%+1.35%+8.65%+10.61%+5.35%+4.55%+18.59%+19.21%+98.59%
2024-10.42%+6.26%-32.23%-34.21%+12.33%-5.22%+13.35%-22.16%+18.20%-2.60%-2.11%-60.09%-82.07%
2023-15.98%-17.07%-4.00%-8.95%+18.43%-0.29%-13.04%+6.09%+23.76%-71.85%+51.45%+41.75%-50.38%
2022-26.83%+4.15%-11.40%-22.76%-16.52%+52.36%-9.64%-5.70%+1.76%+24.17%+6.44%-8.24%-30.25%
2021+8.20%-11.35%-6.72%+6.55%-1.16%-3.54%+7.12%+1.80%-22.83%-4.68%-6.16%-10.14%-38.51%
2020+0.71%-23.08%+3.68%+24.38%-12.15%+10.51%+14.83%+11.36%

Drawdown analysis of Repare Therapeutics (RPTX)

The maximum drawdown for the RPTX was -97.98%, occurring on Apr 10, 2025. This drawdown has not yet recovered.

The current RPTX drawdown is -94.04%.

Since Jun 19, 2020 RPTX has experienced the following drawdowns:

  • 50% or more: 1 time
  • 40% or more: 1 time
  • 30% or more: 3 times
  • 20% or more: 3 times
  • 10% or more: 4 times
DepthStartTo BottomBottomTo RecoverEndTotal
-97.98%Jan 7, 20211069Apr 10, 2025OngoingOngoingOngoing
-34.67%Jun 22, 202023Jul 24, 202037Sep 16, 202060
-30.95%Sep 17, 202018Oct 13, 202035Dec 2, 202053
-16.08%Dec 14, 20207Dec 23, 20209Jan 7, 202116
-3.30%Dec 8, 20203Dec 11, 20201Dec 14, 20204